-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Influenza-virus-IN-2
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2411584-06-8.gif)
| Category | Influenza Virus |
| CAS | 2411584-06-8 |
| Description | Influenza virus-IN-2 (compound 19) is a potent influenza virus inhibitor with an EC50 of 2.58 μM and a CC50 of 150.85 μM. Influenza virus-IN-2 has concentration-dependent inhibitory activity against PAN endonuclease, with an EC50 of 489.39 nM. Influenza virus-IN-2 exhibits activity against influenza A virus. |
Product Information
| Synonyms | Influenza virus-IN-2|CHEMBL4761767|HY-143493|CS-0459558 |
| Molecular Weight | 315.32 |
| Molecular Formula | C17H17NO5 |
| Canonical SMILES | C1CN(CC2=CC(=C(C=C21)O)O)C(=O)CC3=CC(=C(C=C3)O)O |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 431 |
| Exact Mass | 315.11067264 |
| Target | EC50: 2.58 µM (influenza virus); CC50: =150.85 µM (influenza virus) |
| XLogP3-AA | 1.4 |
